| Year |
Citation |
Score |
| 2023 |
Hickerson BT, Petrovskaya SN, Dickensheets H, Donnelly RP, Ince WL, Ilyushina NA. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility. Journal of Virology. 97: e0015423. PMID 37404185 DOI: 10.1128/jvi.00154-23 |
0.325 |
|
| 2018 |
Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW. Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. Plos Pathogens. 14: e1007141. PMID 29924863 DOI: 10.1371/Journal.Ppat.1007141 |
0.328 |
|
| 2018 |
Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW. Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. Plos Pathogens. 14: e1006796. PMID 29346435 DOI: 10.1371/Journal.Ppat.1006796 |
0.416 |
|
| 2015 |
Frank GM, Angeletti D, Ince WL, Gibbs JS, Khurana S, Wheatley AK, Max EE, McDermott AB, Golding H, Stevens J, Bennink JR, Yewdell JW. A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus. Mbio. 6: e01156. PMID 26242629 DOI: 10.1128/Mbio.01156-15 |
0.356 |
|
| 2014 |
Brooke CB, Ince WL, Wei J, Bennink JR, Yewdell JW. Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility. Proceedings of the National Academy of Sciences of the United States of America. 111: 16854-9. PMID 25385602 DOI: 10.1073/Pnas.1415396111 |
0.369 |
|
| 2014 |
Magadán JG, Altman MO, Ince WL, Hickman HD, Stevens J, Chevalier A, Baker D, Wilson PC, Ahmed R, Bennink JR, Yewdell JW. Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes. Plos Pathogens. 10: e1004204. PMID 24945804 DOI: 10.1371/Journal.Ppat.1004204 |
0.338 |
|
| 2013 |
Yewdell JW, Ince WL. Greasing the SCIDs for universal flu antibodies. Cell Host & Microbe. 14: 7-8. PMID 23870308 DOI: 10.1016/J.Chom.2013.07.002 |
0.365 |
|
| 2013 |
Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host & Microbe. 13: 314-23. PMID 23498956 DOI: 10.1016/J.Chom.2013.02.008 |
0.358 |
|
| 2013 |
Ince WL, Gueye-Mbaye A, Bennink JR, Yewdell JW. Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host. Journal of Virology. 87: 4330-8. PMID 23365443 DOI: 10.1128/Jvi.02749-12 |
0.376 |
|
| 2013 |
Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, Yewdell JW. Most influenza a virions fail to express at least one essential viral protein. Journal of Virology. 87: 3155-62. PMID 23283949 DOI: 10.1128/Jvi.02284-12 |
0.413 |
|
| 2012 |
Yewdell JW, Ince WL. Virology. Frameshifting to PA-X influenza. Science (New York, N.Y.). 337: 164-5. PMID 22798590 DOI: 10.1126/Science.1225539 |
0.401 |
|
| 2011 |
Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbò P, Ince WL, Bennink JR, Yewdell JW. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proceedings of the National Academy of Sciences of the United States of America. 108: E1417-22. PMID 22106257 DOI: 10.1073/Pnas.1108754108 |
0.374 |
|
| 2011 |
Anderson JA, Archin NM, Ince W, Parker D, Wiegand A, Coffin JM, Kuruc J, Eron J, Swanstrom R, Margolis DM. Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells. Journal of Virology. 85: 5220-3. PMID 21367910 DOI: 10.1128/Jvi.00284-11 |
0.636 |
|
| 2010 |
Ince WL, Zhang L, Jiang Q, Arrildt K, Su L, Swanstrom R. Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. Journal of Virology. 84: 2740-52. PMID 20042504 DOI: 10.1128/Jvi.02180-09 |
0.635 |
|
| 2009 |
Choudhary SK, Rezk NL, Ince WL, Cheema M, Zhang L, Su L, Swanstrom R, Kashuba AD, Margolis DM. Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse. Journal of Virology. 83: 8254-8. PMID 19494021 DOI: 10.1128/Jvi.00580-09 |
0.649 |
|
| 2009 |
Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. Journal of Virology. 83: 4068-80. PMID 19211740 DOI: 10.1128/Jvi.02486-08 |
0.63 |
|
| 2008 |
Schnell G, Ince WL, Swanstrom R. Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes. Nucleic Acids Research. 36: e146. PMID 18948297 DOI: 10.1093/Nar/Gkn713 |
0.621 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2022 |
Hickerson BT, Adams SE, Barman S, Miller L, Lugovtsev VY, Webby RJ, Ince WL, Donnelly RP, Ilyushina NA. Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression. Antimicrobial Agents and Chemotherapy. e0000922. PMID 35262375 DOI: 10.1128/aac.00009-22 |
0.294 |
|
| 2019 |
Beigel JH, Nam HH, Adams PL, Krafft A, Ince WL, El-Kamary SS, Sims AC. Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference. Antiviral Research. PMID 30974127 DOI: 10.1016/J.Antiviral.2019.04.006 |
0.251 |
|
| 2020 |
Ince WL, Smith FB, O'Rear JJ, Thomson M. Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil. The Journal of Infectious Diseases. PMID 32253432 DOI: 10.1093/infdis/jiaa164 |
0.246 |
|
| 2015 |
Frank GM, Angeletti D, Ince WL, Gibbs JS, Khurana S, Wheatley AK, Max EE, McDermott AB, Golding H, Stevens J, Bennink JR, Yewdell JW. A simple flow-cytometric method measuring B cell surface immunoglobulin avidity enables characterization of affinity maturation to influenza a virus Mbio. 6. DOI: 10.1128/mBio.01156-15 |
0.223 |
|
| 2019 |
Ilyushina NA, Komatsu TE, Ince WL, Donaldson EF, Lee N, O'Rear JJ, Donnelly RP. Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies. Virology Journal. 16: 149. PMID 31783761 DOI: 10.1186/S12985-019-1258-X |
0.212 |
|
| 2009 |
Hurwitz HI, Yi J, Ince W, Novotny WF, Rosen O. The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: Analysis of a phase in study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer Oncologist. 14: 22-28. PMID 19144677 DOI: 10.1634/theoncologist.2008-0213 |
0.074 |
|
| 2005 |
Eberhard DA, Johnson BE, Amler LC, Goddard AD, Heldens SL, Herbst RS, Ince WL, Jänne PA, Januario T, Johnson DH, Klein P, Miller VA, Ostland MA, Ramies DA, Sebisanovic D, et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5900-9. PMID 16043828 DOI: 10.1200/JCO.2005.02.857 |
0.059 |
|
| 2005 |
Ince WL, Jubb AM, Holden SN, Holmgren EB, Tobin P, Sridhar M, Hurwitz HI, Kabbinavar F, Novotny WF, Hillan KJ, Koeppen H. Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab. Journal of the National Cancer Institute. 97: 981-9. PMID 15998951 DOI: 10.1093/jnci/dji174 |
0.052 |
|
| 2004 |
Eberhard D, Amler L, Goddard A, Ince W, Januario T, Hillan K, Ostland M, Ramies D, Seshagiri S, Klein P. 414 Correlation of mutations in EGFR with clinical outcomes in NSCLC patients treated with erlotinib European Journal of Cancer Supplements. 2: 124. DOI: 10.1016/s1359-6349(04)80421-x |
0.035 |
|
| 2020 |
Hill CS, Devesa SC, Ince W, Borg A, Aquilina K. A systematic review of ongoing clinical trials in optic pathway gliomas. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. PMID 32556546 DOI: 10.1007/s00381-020-04724-1 |
0.022 |
|
| Hide low-probability matches. |